Corcept Therapeutics Inc SEC filings CORT
Corcept Therapeutics Inc has 1,001 filings in SEC EDGAR's recent list, going back to Mar 10, 2016. Its latest annual report, Form 10-K, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 29, 2026 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 POS | Filing | May 31, 2024 | — |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| S-8 | Employee stock plan registration | Feb 15, 2022 | — |
| S-8 | Employee stock plan registration | Feb 23, 2021 | — |
| S-8 | Employee stock plan registration | Feb 24, 2020 | — |
| S-8 | Employee stock plan registration | Feb 26, 2019 | — |
| S-8 | Employee stock plan registration | Feb 28, 2018 | — |
| S-3/A | Filing | May 5, 2017 | — |
| S-3 | Shelf registration | Mar 13, 2017 | — |
| S-8 | Employee stock plan registration | Mar 13, 2017 | — |
| S-8 | Employee stock plan registration | Mar 10, 2016 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CORT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1088856
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.